Silicon Valley venture capital firm Kleiner Perkins has made a significant investment in a healthcare AI startup, aiming to enhance regulatory compliance in the industry.
Author: Aino Lehtinen
Aino Lehtinen
Aino Lehtinen is a Finnish journalist and editor originally from Helsinki, Finland. She studied Media and Communication Studies at the University of Tampere, where she developed a strong interest in investigative storytelling and cross-border journalism. After several years working with leading Finnish publications, she relocated to Berlin, Germany, where she currently lives and works as a freelance editor. Lehtinen focuses on issues such as digital privacy, press freedom, and the intersection of media and politics in Europe. Fluent in Finnish, English, and German, she often collaborates with international media outlets on transnational reporting projects.
Turquoise Health raises $40 million to streamline US healthcare’s administrative processes through AI technology.
HEARTio, a medical technology startup, has raised $4.25 million to develop its ECG-based heart attack prediction system, which could revolutionize cardiac care.
Turkish food company ETI announced the appointment of Ercan Oz as its Global CEO, aiming to accelerate the company’s international investments and market share.
Google finalized its $32 billion purchase of cybersecurity firm Wiz following US and EU antitrust approvals. The platform will retain its brand.
Waiv, a spinout from Owkin, has raised $33 million to enhance precision oncology testing using AI technology.
Elon Musk leads the Forbes 2026 list. Global billionaires reached 3,428 individuals this year. Total wealth hit 20.1 trillion dollars amid the AI boom.
VALANX, a Vienna-based biotechnology firm, has successfully raised €3 million in funding from Fujifilm to advance its innovative research aimed at addressing the unmet needs in metastatic breast cancer treatment.
The healthcare workforce platform Carefam has officially launched after securing $14.5 million in funding, aiming to transform the industry.
Combat, a pioneering company in bladder cancer treatment, has successfully raised £2.6 million to advance its Phase 3 clinical trials, marking a significant milestone in cancer research.